Health Condition 1: L80- Vitiligo
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with stable vitiligo lesions with less than 15-20% of BSA involvement.
Exclusion criteria
Exclusion criteria: Patients with unstable , universalis and mucosal vitiligo lesions. Patients who have received any topical medications or systemic treatment during the last 2 months before starting the study. Patients who had any contraindications to phototherapy exposure , e.g., history of presence of malignant or pre - malignant skin lesions. Patients with keloids, hypertrophic scars, photosensitivity conditions and koebner phenomenon. Pregnancy and Lactating females. Patients with unrealistic expectation about the result after treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Two dermatologists will be asked to record the percentage of improvement (repigmentation) for each patient after completion of the treatment by comparing before and after digital photographs by a 5-point scale. Grade 0 (no repigmentation) Grade 1 (1%-5%) Grade 2 (6%-25%) Grade 3 (26%-50%) Grade 4 (51%-75%) Grade 5 (76%-100%) Â Timepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| The patients will also be asked at the final visit to rate the overall satisfaction as Visual assessment score(VAS ,0-10) ; 0 level defined as â??Not satisfied at allâ?? while a level of 10 will be defined as â??completely satisfiedâ??. Timepoint: 3 months | — |
Countries
India
Contacts
Kalinga Institute Of Medical Sciences